Pharmaceutical

Cidara axes 30% of staff to focus on flu prevention drug

The company plans to focus its resources on conducting clinical trials for CD388 influenza prevention therapy.

Sep 14, 2024 - 04:00
Cidara axes 30% of staff to focus on flu prevention drug
The company plans to focus its resources on conducting clinical trials for CD388 influenza prevention therapy.
Read the original article

Tags:

Previous Article

Oncternal stock crashes by 60% as it lays off staff and scraps trials

Next Article

Sobi and Enable Injections partner for Aspaveli distribution

What's Your Reaction?

like

dislike

love

funny

angry

sad

wow

Related Posts

FORE Biotherapeutics raises funding to expedite plixorafenib development

FORE Biotherapeutics raises funding to expedite plixora...

Aug 24, 2023

How the GLP-1 receptor agonist market could hit $168bn by 2033

How the GLP-1 receptor agonist market could hit $168bn ...

Aug 11, 2024

STAT+: Neuralink can now study its brain implant in humans, but it’s still catching up to its peers

STAT+: Neuralink can now study its brain implant in hum...

May 27, 2023